Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist

Intern Med. 2020;59(16):1977-1981. doi: 10.2169/internalmedicine.4554-20. Epub 2020 Aug 15.

Abstract

A 45-year-old man with steroid-dependent ulcerative pancolitis was hospitalized with frequent diarrhea, abdominal pain and distension 3 months after induction of golimumab, a tumor necrosis factor-alpha antagonist. Computed tomography showed wall thickening from the stomach to the colon and massive ascites. Peripheral blood test revealed eosinophilia. A large number of eosinophils were observed in the ascites fluid. Although esophagogastroduodenoscopy showed no abnormal findings and colonoscopy showed ulcerative colitis with a Mayo endoscopic subscore of 1, eosinophil infiltration was histologically observed. Based on these findings, we diagnosed him with eosinophilic gastroenteritis and started prednisolone. Consequently, his eosinophil counts and abdominal symptoms dramatically improved.

Keywords: ascites; eosinophilic gastroenteritis; prednisolone; tumor necrosis factor-alpha antagonist; ulcerative colitis.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Ascites / chemically induced
  • Ascites / diagnostic imaging
  • Colitis, Ulcerative / drug therapy*
  • Colonoscopy
  • Endoscopy, Digestive System
  • Enteritis / chemically induced*
  • Enteritis / diagnostic imaging
  • Enteritis / drug therapy
  • Enteritis / pathology
  • Eosinophilia / chemically induced*
  • Eosinophilia / diagnosis
  • Eosinophilia / diagnostic imaging
  • Eosinophilia / drug therapy
  • Eosinophilia / pathology
  • Eosinophils / pathology
  • Esophagus / pathology
  • Gastritis / chemically induced*
  • Gastritis / diagnostic imaging
  • Gastritis / drug therapy
  • Gastritis / pathology
  • Glucocorticoids / therapeutic use
  • Humans
  • Ileum / pathology
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Rectum / pathology
  • Stomach / pathology
  • Tomography, X-Ray Computed
  • Tumor Necrosis Factor Inhibitors / adverse effects*

Substances

  • Antibodies, Monoclonal
  • Glucocorticoids
  • Tumor Necrosis Factor Inhibitors
  • golimumab
  • Prednisolone

Supplementary concepts

  • Eosinophilic enteropathy